Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 1—January 2022

High-Level Quinolone-Resistant Haemophilus haemolyticus in Pediatric Patient with No History of Quinolone Exposure

Emi Tanaka1, Yuji Hirai1, Takeaki WajimaComments to Author , Yu Ishida, Yoshiaki Kawamura, and Hidemasa Nakaminami
Author affiliations: Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan (E. Tanaka, T. Wajima, H. Nakaminami); Meijo University, Nagoya, Japan (E. Tanaka, T. Wajima); Tokyo Medical University Hachioji Medical Centre, Tokyo (Y. Hirai, Y. Ishida); Aichi Gakuin University, Nagoya, Japan (Y. Kawamura)

Main Article

Table 3

Amino acid substitutions in quinolone target protein of Haemophilus haemolyticus strain 2019-19 from a 9-year-old girl in Japan*

GyrA GyrB ParC ParE
S84L A567T S84R P439S
D88Y N631S S138T L502F
H212Y A725V V214I D596N
T251S V270I A599S
D740E D442N
S784N M591I

*Compared with H. haemolyticus CCUG 12834T or ATCC 33390T, NCTC10839, M19346, and M28486

Main Article

1These authors contributed equally to this article.

Page created: November 10, 2021
Page updated: December 22, 2021
Page reviewed: December 22, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.